Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies Read more
Bicycle Therapeutics and Cancer Research UK to collaborate on development of new Bicycle immuno-oncology candidate, BT7401 Read more
Veristat Strengthens Its European Presence with the Acquisition of The Clinical Trial Company Read more
InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab Read more
Pulmatrix Announces Research Collaboration with Nocion Therapeutics to Explore Inhaled Drug Delivery Technologies Read more